Continued Innovation creates affordable healthcare technologies or products which do not exist in Indian markets. This includes products which either needs modifications through re-engineering; or product which exists, but affordable and cost effective versions are required; and/or those products which exist, but their usage is limited due to lack of optimal transport and storage conditions etc. Availability of affordable healthcare, thereby, is a challenge to the Indian Health Care Providers.
To mitigate this challenge, Department of Biotechnology (DBT) invites proposals under Biotechnology Industry Partnership Programme (BIPP), a Government partnership with industry for support on a cost sharing basis, exclusively in the field of Innovative and Affordable Health Technologies for Women, Child Care and Other Age Groups, which may include one or more of the following innovative element(s), but not limited to:
1. Neonatal Implants
5. Laryngeal mask airway tube
6. Elemental Fortification
7. Improved Clean Delivery Kits
8. Control of Postpartum haemorrhage
9. Control and containment of Infections of the umbilical cord
10. Prevention of mother-to-child transmission (PMTCT) of HIV/AIDS
11. Value additions in Immunization Process
12. Preventive Technologies
a. Respiratory Syncytial Virus Vaccines
b. Pneumococcal protein & polysaccharide conjugate Vaccine
c. Papilloma Virus Vaccines
13. Cheaper Renal Dialysis technologies
a. Glucose Monitoring for diabetics
b. Affordable bone density assessing technology
c. Pre-screening test for blood bank safety
d. Pre-natal diagnostic technology
e. Diagnostic test for the early detection of cardiovascular diseases
f. Point-of-care tests and reagents for cancer screening
g. Appropriate, low-cost diagnostic imaging devices for low-resources settings
h. Diagnostics that make a dent on patient treatment and disease surveillance
14. Information and Communication technologies which have transformative effect on health care access and responsiveness of healthcare system.
15. Technologies to produce affordable versions of existing Imported models having therapeutic value.
Validation of Technologies Transferred /acquired from other countries by Indian companies for product development in India can also be supported keeping in view the unmet national needs and/or affordability of the product by Indian customers.
Announcement Date: 21-11-2010
Last Submission Date: 22-12-2010 12:00 AM
© 2020 B I R A C